Tat peptide-decorated gelatin-siloxane nanoparticles for delivery of CGRP transgene in treatment of cerebral vasospasm

International Journal of Nanomedicine

Volumn 8, Issue , 2013, Pages 865-876

  Tian, Xin Hua ^a,b   Wang, Zhi Gang ^a,b   Meng, Han ^a,b   Wang, Yu Hua ^b   Feng, Wei ^b   Wei, Feng ^b   Huang, Zhi Chun ^b   Lin, Xiao Ning ^b   Ren, Lei ^b,c  

^a FUJIAN MEDICAL UNIVERSITY   (China)

^b XIAMEN UNIVERSITY   (China)

^c XIAMEN UNIVERSITY   (China)

Author keywords

Calcitonin gene related peptide; Cerebral vasospasm; Gene transfer; Nanoparticles

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; NANOPARTICLE; PLASMID VECTOR; TAT PEPTIDE DECORATED GELATIN SILOXANE NANOPARTICLE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; BRAIN VASOSPASM; CAPILLARY ENDOTHELIUM; CELL TRANSPORT; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE DELIVERY SYSTEM; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; NANOANALYSIS; NANOENCAPSULATION; NONHUMAN; RAT; SUBARACHNOID HEMORRHAGE; TRANSGENE;

CALCITONIN GENE-RELATED PEPTIDE; CEREBRAL VASOSPASM; GENE TRANSFER; NANOPARTICLES;

ANIMALS; BEHAVIOR, ANIMAL; CALCITONIN GENE-RELATED PEPTIDE; CELL LINE, TRANSFORMED; CELL SURVIVAL; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; GELATIN; HUMANS; MALE; NANOCAPSULES; PARTICLE SIZE; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; SILOXANES; SUBARACHNOID HEMORRHAGE; SUBARACHNOID SPACE; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; TRANSFECTION; TRANSGENES; VASOSPASM, INTRACRANIAL;

RATTUS;

EID: 84875898060     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S39951     Document Type: Article

References (37)

1. Seiler RW, Grolimund P, Zurbruegg HR. Evaluation of the calcium-antagonist nimodipine for the prevention of vasospasm after aneurysmal subarachnoid haemorrhage. A prospective transcranial Doppler ultrasound study. Acta Neurochir (Wien). 1987;85(1-2):7-16.
2. Brain SD, Grant AD. Vascular actions of calcitonin gene-related peptide and adrenomedullin. Physiol Rev. 2004;84(3):903-934.
3. Satoh M, Perkins E, Kimura H, et al. Post treatment with adenovirus-mediated gene transfer of calcitonin gene-related peptide to reverse cerebral vasospasm in dogs. J Neurosurg. 2002;97(1): 136-142.
4. Toyoda K, Faraci FM, Watanabe Y, et al. Gene transfer of CGRP prevents vasoconstriction after subarachnoid hemorrhage. Circ Res. 2000;87(9):818-824.
5. Mesis RG, Wang H, Lombard FW, et al. Dissociation between vasospasm and functional improvement in a murine model of subarachnoid hemorrhage. Neurosurg Focus. 2006;21(3):E4.
6. Driesse MJ, Esandi MC, Kros JM, et al. Intra-CSF administered recombinant adenovirus causes an immune response-mediated toxicity. Gene Ther. 2000;7(16):1401-1409.
7. Driesse MJ, Kros JM, Avezaat CJJ, et al. Distribution of recombinant adenovirus in the cerebrospinal fluid of nonhuman primates. Hum Gene Ther. 1999;10(14):2347-2354.
8. Dang JM, Leong KW. Natural polymers for gene delivery and tissue engineering. Adv Drug Deliv Rev. 2006;58(4):487-499.
9. Luo D, Han E, Belcheva N, Saltzman WM. A self-assembled, modular DNA delivery system mediated by silica nanoparticles. J Control Release. 2004;95(2):333-341.
10. Bharali DJ, Klejbor I, Stachowiak EK, et al. Organically modified silica nanoparticles: a nonviral vector for in vivo gene delivery and expression in the brain. Proc Natl Acad Sci U S A. 2005;102(32):11539-11544.
11. Wang ZY, Zhao Y, Ren L, et al. Novel gelatin-siloxane nanoparticles decorated by Tat peptide as vectors for gene therapy. Nanotechnology. 2008;19(44):445103.
12. Tian XH, Wei F, Wang TX, et al. In vitro and in vivo studies on gelatin-siloxane nanoparticles conjugated with SynB peptide to increase drug delivery to the brain. Int J Nanomedicine. 2012;7:1031-1041.
13. Tian XH, Wei F, Wang TX, et al. Blood-brain barrier transport of Tat peptide and polyethylene glycol decorated gelatin-siloxane nanoparticles. Mater Lett. 2012;68:94-96.
14. Dusick JR, Evans BC, Laiwalla A, Krahl S, Gonzalez NR. A minimally-invasive rat model of subarachnoid hemorrhage and delayed ischemic injury. Surg Neurol Int. 2011;2:99.
15. Yokoo N, Sheng H, Mixco J, Homi HM, Pearlstein RD, Warner DS. Intraischemic nitrous oxide alters neither neurologic nor histologic outcome: a comparison with dizocilpine. Anesth Analg. 2004;99(3):896-903.
16. Meguro T, Clower BR, Carpenter R, Parent AD, Zhang JH. Improved rat model for cerebral vasospasm studies. Neurol Res. 2001;23(7): 761-766.
17. Surendiran A, Sandhiya S, Pradhan SC, Adithan C. Novel applications of nanotechnology in medicine. Indian J Med Res. 2009;130(6): 689-701.
18. Brooks H, Lebleu B, Vives E. Tat peptide-mediated cellular delivery: back to basics. Adv Drug Deliv Rev. 2005;57(4):559-577.
19. Berry CC. Intracellular delivery of nanoparticles via the HIV-1 tat peptide. Nanomedicine. 2008;3(3):357-365.
20. Song HP, Yang JY, Lo SL, et al. Gene transfer using self-assembled ternary complexes of cationic magnetic nanoparticles, plasmid DNA and cell-penetrating Tat peptide. Biomaterials. 2010;31(4):769-778.
21. Xu ZP, Zeng QH, Lu GQ, Yu AB. Inorganic nanoparticles as carriers for efficient cellular delivery. Chem Eng Sci. 2006;61(3):1027-1040.
22. Suzuki H, Kanamaru K, Tsunoda H, et al. Heme oxygenase-1 gene induction as an intrinsic regulation against delayed cerebral vasospasm in rats. J Clin Invest. 1999;104(1):59-66.
23. Stoodley M, Weihl CC, Zhang Z, et al. Effect of adenovirus-mediated nitric oxide synthase gene transfer on vasospasm after experimental subarachnoid hemorrhage. Neurosurgery. 2000;46(5):1193-1203.
24. Ohkuma H, Parney I, Megyesi J, Ghahary A, Findlay JM. Antisense preproendothelin-oligoDNA therapy for vasospasm in a canine model of subarachnoid hemorrhage. J Neurosurg. 1999;90(6):1105-1114.
25. Ono S, Date I, Onoda K, et al. Decoy administration of NF-κB into the subarachnoid space for cerebral angiopathy. Hum Gene Ther. 1998;9(7): 1003-1011.
26. Ono S, Komuro T, Macdonald RL. Heme oxygenase-1 gene therapy for prevention of vasospasm in rats. J Neurosurg. 2002;96(6): 1094-1102.
27. Yamaguchi M, Zhou C, Heistad DD, Watanabe Y, Zhang JH. Gene transfer of extracellular superoxide dismutase failed to prevent cerebral vasospasm after experimental subarachnoid hemorrhage. Stroke. 2004;35(11):2512-2517.
28. Kallner G, Franco-Cereceda A. Aggravation of myocardial infarction in the porcine heart by capsaicin-induced depletion of calcitonin gene-related peptide (CGRP). J Cardiovasc Pharmacol. 1998;32(3):500-504.
29. Li YJ, Song QJ, Xiao J. Calcitonin gene-related peptide: an endogenous mediator of preconditioning. Acta Pharmacol Sin. 2000;21(10): 865-869.
30. Su H, Joho S, Huang Y, et al. Adeno-associated viral vector delivers cardiac-specific and hypoxia-inducible VEGF expression in ischemic mouse hearts. Proc Natl Acad Sci U S A. 2004;101(46): 16280-16285.
31. Medley CD, Bamrungsap S, Tan W, Smith JE. Aptamer-conjugated nanoparticles for cancer cell detection. Anal Chem. 2011;83(3): 727-734.
32. Dhar S, Gu FX, Langer R, Farokhzad OC, Lippard SJ. Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA-PEG nanoparticles. Proc Natl Acad Sci U S A. 2008;105(45):17356-17361.
33. Pislaru S, Janssens SP, Gersh BJ, Simari RD. Defining gene transfer before expecting gene therapy: putting the horse before the cart. Circulation. 2002;106(5):631-636.
34. Shimamura M, Sato N, Waguri S, et al. Gene transfer of hepatocyte growth factor gene improves learning and memory in the chronic stage of cerebral infarction. Hypertension. 2006;47(4):742-751.
35. Gules I, Saton M, Clower BR, Nanda A, Zhang JH. Comparison of three rat models of cerebral vasospasm. Am J Physiol Heart Circ Physiol. 2002;283(6):H2551-H2559.
36. Frederickson RG, Low FN. Blood vessels and tissue space associated with the brain of the rat. Am J Anat. 1969;125(2):123-145.
37. Kader A, Krauss WE, Onesti ST, Elliott JP, Solomon RA. Chronic cerebral blood flow changes following experimental subarachnoid hemorrhage in rats. Stroke. 1990;21(4):577-581.